相关实验视频

Updated: Jun 3, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

铁亡:一种针对黑色素瘤治疗的有针对性的脆弱性

Yu Meng¹, Qian Zhou¹, Yating Dian¹

¹Department of Dermatology, Xiangya Hospital, Central South University, Changsha, China; National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Changsha, China; Furong Laboratory, Changsha, China; Hunan Key Laboratory of Skin Cancer and Psoriasis, Hunan Engineering Research Center of Skin Health and Disease, Xiangya Hospital, Central South University, Changsha, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Changsha, China.

The Journal of investigative dermatology

|January 11, 2025

概括

细胞死亡途径 - - 铁亡 - - 对治疗黑色素瘤 - - 一种具有挑战性的皮肤癌 - - 是有前途的. 了解黑色素瘤生物学中的铁亡是开发新型有效疗法的关键.

科学领域:

在瘤学瘤学.
细胞生物学细胞生物学
癌症研究癌症研究

背景情况:

黑色素瘤具有很高的突变负担,治疗成功有限,预后不佳.
目前的免疫疗法和向治疗只能为一小部分患者提供持久反应.
迫切需要新的治疗策略来治疗黑色素瘤.

研究的目的:

审查铁灭的分子机制.
探索黑色素瘤生物学在铁亡调节中的作用.
讨论铁死在黑色素瘤中的治疗潜力,并指导未来的研究.

主要方法:

关于铁亡机制的文献综述.
对影响铁亡的黑色素瘤生物学特征的分析.
检查瘤微环境中的免疫细胞中铁灭的作用.

主要成果:

铁,一种依赖于铁的细胞死亡,是由脂质过氧化物积累驱动的.
黑色素瘤的表型可塑性,代谢状态以及遗传/表观遗传变化会影响铁亡.
铁死在临床前黑色素瘤模型中表现出治疗潜力.

结论:

铁化是黑色素瘤的一个有前途的治疗途径.
了解黑色素瘤生物学中的铁化对于治疗开发至关重要.
需要进一步的研究来解决有关黑色素瘤中铁亡的关键问题.

关键词:

铁化是铁化的一种.免疫系统的免疫系统.黑色素瘤是一种黑色素瘤.代谢过程中的代谢.

更多相关视频

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles

Published on: May 14, 2021

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts

Published on: February 23, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Necrosis

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...